Second-line bevacizumab plus FOLFOX in patients with metastatic colorectal cancer previously treated with adjuvant oxaliplatin-based chemotherapy.

被引：0
|
作者：
Chun, Sang Hoon
Kim, Jung Hoon
Kwag, Seung-Jin
Kang, Myoung Hee
Park, Ji-Ho
Lee, Gyeong-Won
Kang, Jung Hun
机构：
[1] Catholic Univ Korea, Bucheon St Marys Hosp, Dept Internal Med, Div Hematol Oncol, Bucheon Si, South Korea
[2] Gyeongsang Natl Univ Hosp, Dept Internal Med, Div Hematol Oncol, Jinju Si, South Korea
[3] Gyeongsang Natl Univ Hosp, Jinju Si, South Korea
[4] Gyeongsang Natl Univ, Sch Med, Jinju Si, South Korea
[5] Gyeongsang Natl Univ, Jinju Si, South Korea
[6] Gyeongsang Natl Univ, Coll Med, Gyeongsang Natl Univ Hosp, Div Hematol & Oncol,Dept Internal Med, Jinju, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
157
引用
收藏
页码：157 / 157
页数：1
相关论文
共 50 条
  • [41] EFFECTIVENESS OF CHEMOTHERAPY WITH OXALIPLATIN, CAPECITABINE AND BEVACIZUMAB (XELOX plus BEV) IN SECOND LINE THERAPY OF METASTATIC COLORECTAL CANCER (MCRC)
    Arzykulov, Z.
    Chichua, N.
    Smagulova, K.
    Khamidullina, G.
    Mukanova, S.
    Suriya, K.
    ANNALS OF ONCOLOGY, 2010, 21 : 32 - 32
  • [42] Evaluation of FOLFOX or CAPOX reintroduction with or without bevacizumab in relapsed colorectal cancer patients treated with oxaliplatin as adjuvant chemotherapy (REACT study)
    Masahito Kotaka
    Shigeyoshi Iwamoto
    Hironaga Satake
    Daisuke Sakai
    Toshihiro Kudo
    Mutsumi Fukunaga
    Ken Konishi
    Yoshihito Ide
    Taro Ikumoto
    Akihito Tsuji
    Yasushi Sano
    Takeshi Kato
    Naotoshi Sugimoto
    Taroh Satoh
    Akiyoshi Kanazawa
    Takayasu Kurata
    Takeharu Yamanaka
    Naohiro Tomita
    International Journal of Clinical Oncology, 2020, 25 : 1515 - 1522
  • [43] Comparison between three oxaliplatin-based regimens with bevacizumab in patients with metastatic colorectal cancer
    Ohhara, Yoshihito
    Suenaga, Mitsukuni
    Matsusaka, Satoshi
    Shinozaki, Eiji
    Mizunuma, Nobuyuki
    Yamaguchi, Toshiharu
    ONCOTARGETS AND THERAPY, 2015, 8 : 529 - 537
  • [44] Cetuximab plus oxaliplatin-based chemotherapy in the treatment of colorectal cancer
    Moosmann, Nicolas
    Heinemann, Volker
    EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (03) : 319 - 329
  • [45] Efficacy and safety of CapeIRI plus bevacizumab therapy as a second-line treatment for patients with metastatic colorectal cancer
    Sunagawa, Y.
    Nakayama, G.
    Hattori, N.
    Ezaka, K.
    Uda, H.
    Umeda, S.
    Sato, B.
    Yamada, S.
    Sugimito, H.
    Koike, M.
    Kodera, Y.
    ANNALS OF ONCOLOGY, 2017, 28
  • [46] Oxaliplatin-based chemotherapy in the treatment of elderly patients with metastatic colorectal cancer (CRC)
    Berretta, Massimiliano
    Zanet, Ernesto
    Nasti, Guglielmo
    Lleshi, Arben
    Frustaci, Sergio
    Fiorica, Francesco
    Bearz, Alessandra
    Talamini, Renato
    Lestuzzi, Chiara
    Lazzarini, Renzo
    Fisichella, Rossella
    Cannizzaro, Renato
    Iaffaioli, Rosario Vincenzo
    Berretta, Salvatore
    Tirelli, Umberto
    ARCHIVES OF GERONTOLOGY AND GERIATRICS, 2012, 55 (02) : 271 - 275
  • [47] NEUTROPENIA AND GENDER DIFFERENCIES AT LIVER-ONLY METASTATIC COLORECTAL CANCER PATIENTS TREATED WITH OXALIPLATIN-BASED NEOADJUVANT CHEMOTHERAPY PLUS BEVACIZUMAB: IS THERE ANY IMPACT ON RESECTION RATE?
    Radosavljevic, D.
    Nikolic, N.
    Jovanovic, J.
    Nikolic, V.
    Gavrilovic, D.
    Jelic, S.
    ANNALS OF ONCOLOGY, 2010, 21 : 217 - 217
  • [48] Irinotecan and mitomycin C (MMC) as salvage therapy for patients with metastatic colorectal cancer previously treated with fluoropyrimidine, irinotecan and/or oxaliplatin based chemotherapy.
    Rodriguez, I
    Viudez, A
    Salgado, E
    García-Foncillas, J
    De La Cámara, J
    Espinós, J
    Garrán, C
    Chopitea, A
    Fernández-Hidalgo, O
    Martín-Algarra, S
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 308S - 308S
  • [49] Flashback Foreword: Bevacizumab and FOLFOX4 for Colorectal Cancer and Bevacizumab Versus Placebo Plus Oxaliplatin-Based Chemotherapy in Metastatic Colorectal Cancer (Reprinted from vol 25, pg 1539-1544, 2007)
    O'Reilly, Eileen M.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (21) : 3661 - +
  • [50] Evaluation of safety of bevacizumab as second-line treatment of patients with metastatic colorectal cancer
    Todorovic, Vladimir
    Saric, Nada Cicmil
    Lakicevic, Jadranka
    Sorat, Milan
    JOURNAL OF BUON, 2017, 22 (05): : 1131 - 1136
12345